Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

BridgeBio Pharma Q4 EPS $(0.96) Misses $(0.91) Estimate, Sales $1.75M Down From $1.87M YoY

Author: Benzinga Newsdesk | February 22, 2024 08:50am
BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.96) per share which missed the analyst consensus estimate of $(0.91) by 5.49 percent. This is a 4.35 percent decrease over losses of $(0.92) per share from the same period last year. The company reported $1.75 million in sales this quarter. This is a 6.68 percent decrease over sales of $1.87 million the same period last year.

Posted In: BBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist